Swiss pharmaceutical company Novartis AG /quotes/zigman/171707/quotes/nls/nvs NVS -1.38% said Monday it is planning to invest over 500 million Swiss francs ($550 million) building a new manufacturing facility in Switzerland.
MAIN FACTS:
-The company said the investment underlines the long-term strategy of Novartis to establish a worldwide manufacturing network of technology centers.
-The new production site in Stein, Switzerland, is expected to be fully operational by end of 2016.
